FIGNL1 Activators
The class of chemicals listed as FIGNL1 Activators includes various compounds that indirectly influence FIGNL1 through their effects on DNA repair mechanisms and related signaling pathways. These compounds are not direct activators of FIGNL1 but may impact its function by modulating the cellular environment and processes related to DNA repair.Poly (ADP-ribose) polymerase (PARP) inhibitors such as Olaparib, Rucaparib, Niraparib, Veliparib, and Talazoparib are known for their role in inhibiting DNA repair, particularly in cells deficient in homologous recombination repair mechanisms. By influencing DNA repair pathways, these inhibitors may indirectly affect the function of FIGNL1, which is involved in DNA repair processes.
Inhibitors targeting key proteins involved in the DNA damage response, such as ATR, ATM, CHK1, CHK2, and DNA-PK, can also indirectly impact FIGNL1. These inhibitors alter the cellular response to DNA damage and the regulation of cell cycle checkpoints, which are important processes in DNA repair where FIGNL1 is involved.Compounds like B02, which stabilize RAD51, can enhance homologous recombination, a pathway in which FIGNL1 plays a significant role. Similarly, inhibitors of BRCA1/2, such as MLN4924, by affecting homologous recombination, could indirectly influence FIGNL1
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib, a PARP inhibitor, may indirectly affect FIGNL1 by influencing DNA repair pathways, especially homologous recombination. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Rucaparib, another PARP inhibitor, could indirectly impact FIGNL1 function by modulating DNA repair mechanisms. | ||||||
Niraparib | 1038915-60-4 | sc-507492 | 10 mg | $150.00 | ||
Niraparib, also a PARP inhibitor, may influence FIGNL1 activity indirectly through its role in DNA repair and recombination. | ||||||
Veliparib | 912444-00-9 | sc-394457A sc-394457 sc-394457B | 5 mg 10 mg 50 mg | $182.00 $275.00 $726.00 | 3 | |
Veliparib, a PARP inhibitor, could indirectly affect FIGNL1 by altering DNA damage response and repair pathways. | ||||||
Talazoparib | 1207456-01-6 | sc-507440 | 10 mg | $795.00 | ||
Talazoparib, a potent PARP inhibitor, may impact FIGNL1 indirectly through its effects on DNA repair mechanisms. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
ATR inhibitors, like VE-821, could influence FIGNL1 function indirectly by modulating DNA damage response and repair pathways. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
ATM inhibitors, such as KU-55933, may affect FIGNL1 activity indirectly by influencing DNA repair and cellular response to DNA damage. | ||||||
PF 477736 | 952021-60-2 | sc-362781 sc-362781A | 5 mg 25 mg | $115.00 $431.00 | ||
CHK1 inhibitors, like PF-477736, could indirectly impact FIGNL1 by altering cell cycle checkpoints and DNA repair processes. | ||||||
RAD51 Inhibitor B02 | 1290541-46-6 | sc-507533 | 10 mg | $95.00 | ||
Compounds that stabilize RAD51, like B02, could affect FIGNL1 function indirectly by enhancing homologous recombination. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $106.00 | 8 | |
Inhibitors of BRCA1/2, such as MLN4924, may impact FIGNL1 indirectly by influencing DNA repair pathways, including homologous recombination. | ||||||